Zafgen makes new appointment
This article was originally published in Scrip
Executive Summary
Zafgen, a US biopharmaceutical company developing obesity therapeutics, has appointed Matthias Jaffe chief financial officer and vice-president of business development. Mr Jaffe has served as CFO at a number of life science organisations, most recently with Alantos Pharmaceuticals.